3-(1,3-Dioxolan-2-yl)-4'-methylbenzophenone, 97.0%, 1g

2,5-Dibromo-3-fluoropyridine, 98.0%, 25g

Ethyl 2-amino-thiazole-5-carboxylate, 97.0%, 100g

1-(DIFLUOROMETHYL)-1H-PYRAZOL-4-AMINE, 95.0%, 5g

(2R,5S)-2,5-Dimethyl-1-(phenylmethyl)piperazine, 98%, 500mg

3-Chloro-4-(4'-fluorobenzyloxy)phenylboronic acid, 98%, 1g

2-Chloro-6-methylnicotinaldehyde, 95%, 5g

4-(2-Hydroxyethyl)cyclohexanone, 95.0%, 100mg

(5R,9R,E)-5-Amino-11-ethylidene-7-methyl-5,6,9,10-tetrahydro-5,9-methanocycloocta[b]pyridin-2(1H)-one, 95.0%, 100mg

4-Bromo-3'-chlorobiphenyl, 97.0%, 100g

4-Benzyloxyindole, 98.0%, 5g

Pointes de pipettes MIKRO 0,1–10 μl avec graduation, Boîte, 960 pièces, Non stérile, 960 pièces

Hexabromostearic Acid>93.0%(T)25g